Lang H, Oldhafer K J, Schlitt H J, Scheumann G F, Ringe B, Pichlmayr R
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover.
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:416-8.
Between 1982 and February 1996 11 patients underwent liver transplantation for irresectable neuroendocrine hepatic metastases. The operative mortality was one of 11, while two patients died due to sepsis respectively tumor recurrence 7 and 68 months after transplantation. Eight patients are alive with a median survival of 55 months (range from 10 days to 8.5 years). In three patients there is no evidence of tumor and the longest disease-free survival is 102 months after LTx. These results suggest that liver transplantation represents a justified treatment for irresectable hepatic metastases arising from neuroendocrine tumors.
1982年至1996年2月期间,11例患者因无法切除的神经内分泌肝转移瘤接受了肝移植手术。手术死亡率为11例中的1例,另有2例患者分别在移植后7个月和68个月因败血症和肿瘤复发死亡。8例患者存活,中位生存期为55个月(范围从10天至8.5年)。3例患者无肿瘤证据,肝移植后最长无病生存期为102个月。这些结果表明,肝移植是治疗神经内分泌肿瘤引起的无法切除的肝转移瘤的合理方法。